Drawing for IPS STOCK

USPTO serial 79294318

IPS STOCK

Reviewed by CopyMark Law Group

Reg. 6630776Status 700Renewal
Filing date
Status date
Registration date
Feb 1, 2022
Examiner
CLAYTON, CHERYL A
Law office
TMEG LAW OFFICE 102

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IPS STOCK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*

Plus Government fees of $1,625

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dawn Rudenko

Dawn Rudenko Holland & Knight LLP263 Tresser BlvdOne Stamford Plaza, Ste1400Stamford, CT 06901

Goods and services

ClassDescriptionStatusFirst use
001Stem cells for research and scientific purposes; stem cells, other than for medical or veterinary purposes; chemicals used in industry; plant growth regulating preparations; fertilizers; chemical test paper, other than for medical purposesACTIVE—
005Stem cells for medical and clinical purposes; pharmaceutical preparations for use in regenerative therapy; test paper, namely, reagent paper for medical purposesACTIVE—
039Storage of frozen living cells; storage of tissues, cells and stem cells; warehousing services for deposited articlesACTIVE—
042Research in the field of stem cells; commissioned cell cultures for scientific purposes, namely, custom design and development of cell cultures for scientific use; cell or gene examination in the nature of research on cells and genes; testing and examination on cells; research and development in the field of cells; testing, examination, research and development in the field of regenerative medicine; testing, examination, research and development of pharmaceuticals; scientific research in the field of culture of cells for transplantation collected from a patient itself; clinical study in the medical field; providing quality assurance services in the field of cells; quality control for others; providing information on medical research in the field of medical therapy; providing information on testing, inspection, or research related to medical science using stem cells; providing information related to research and development of pharmaceutical preparations; scientific testing, analysis, or research on treatment method and treatment technique related to medical care; testing, inspection or research of cosmetics or foods; design and development of computer hardware and computer software for use in the field of medical science; designing of machines, apparatus, instruments, including their parts, or systems composed of such machines, apparatus and instruments; design, development or maintenance of computer programs; testing the functionality of machines, apparatus, and instruments or research on machines apparatus, and instruments; rental of laboratory apparatus and instrumentsACTIVE—
044Stem cell therapy; providing medical information in the field of cells; providing medical information on regenerative medicine; providing medical information; collection and preservation of biological tissues, blood and cells; medical treatment and diagnosis in the nature of regenerative therapy by culture of medical and clinical cells; medical care; providing information and data for diagnosis and medical treatment in the nature of medical information; medical treatment or diagnosis in the nature of regenerative therapy using regenerative medicine; medical treatment or diagnosis in the nature of regenerative cell therapy; medical treatment in the nature of regenerative therapy; professional medical consulting services in the field of cell preparations to treat diseases; preservation of human blood for use as a supply source of stem cells; clinical examination in the nature of medical examination services; provision of patient clinical medical information and medical record analysis for use in medical treatment, diagnosis and prevention; medical treatment in the nature of regenerative therapy using cultured cells; [ preparation and dispensing of medications; ] physical examination services; [ dentistry services; ] providing health information; dietary and nutritional guidance; rental of medical apparatus; commissioned cell culture services for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 5, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 15, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 15, 2022FIMPFINAL DISPOSITION PROCESSED—
Jul 18, 2022LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Jul 15, 2022COC.CORRECTION UNDER SECTION 7 - PROCESSED—
May 1, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 25, 2022LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Feb 1, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 29, 2021GPNXNOTIFICATION PROCESSED BY IB—
Nov 26, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 16, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 16, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 27, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 27, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 27, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 8, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 5, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 5, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 5, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 11, 2021RFNTREFUSAL PROCESSED BY IB—
Apr 13, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 13, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 13, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 12, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 12, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 12, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 27, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 9, 2020RFNTREFUSAL PROCESSED BY IB—
Oct 19, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 19, 2020RFRRREFUSAL PROCESSED BY MPU—
Oct 2, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 29, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 28, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2020DOCKASSIGNED TO EXAMINER—
Sep 28, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 24, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance